Receptor cross-linking restores an insulin metabolic effect altered by mutation on tyrosine 1162 and tyrosine 1163
- 10 January 1989
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 28 (1) , 14-17
- https://doi.org/10.1021/bi00427a003
Abstract
Note: In lieu of an abstract, this is the article's first page.This publication has 9 references indexed in Scilit:
- Monoclonal antibodies to the insulin receptor stimulate the intrinsic tyrosine kinase activity by cross-linking receptor molecules.The EMBO Journal, 1987
- Reevaluation of the evidence that an antibody to the insulin receptor is insulinmimetic without activating the protein tyrosine kinase activity of the receptor.Journal of Biological Chemistry, 1987
- Monoclonal antibodies to the human insulin receptor that activate glucose transport but not insulin receptor kinase activity.Proceedings of the National Academy of Sciences, 1987
- Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin.Journal of Biological Chemistry, 1987
- Insulin and rabbit anti-insulin receptor antibodies stimulate additively the intrinsic receptor kinase activity.The EMBO Journal, 1987
- Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucoseCell, 1986
- Insulin Receptor Phosphorylation May Not Be a Prerequisite for Acute Insulin ActionScience, 1984
- Biological role of epidermal growth factor-receptor clustering. Investigation with monoclonal anti-receptor antibodies.Journal of Biological Chemistry, 1983
- Direct demonstration that receptor crosslinking or aggregation is important in insulin actionProceedings of the National Academy of Sciences, 1978